THOUSAND OAKS Calif. Sept. 20 2016 PRNewswire &160;Amgen NASDAQAMGN today announced that the Phase 3 GLAGOV GLobal Assessment of Plaque ReGression with a PCSK9 AntibOdy as Measured by IntraVascular Ultrasound trial evaluating the effect of Repatha&...
↧